Angiodynamics price to free cash flow ANGO

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 360×
10-year median: 21.6×
Against its 10-year history: 99th; percentile: 0 is its lowest day, 100 its highest
10-year range: 10.6× to 368×
Peer median: 14.9×

Angiodynamics' price to free cash flow is 360× as of Oct 23, 2026.

That is above its ten-year median of 21.6×, higher than on 99% of days in the last ten years.

Over that time it ranged from 10.6× in Apr 2017 to 368× in Jun 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 14.9×.

Price to free cash flow over time

median 21.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	360×	269×	368×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	125×	115×	134×
2021	65.7×	49.2×	110×
2020	13.4×	12.0×	21.5×
2019	16.7×	14.9×	29.8×
2018	27.9×	13.4×	30.1×
2017	12.6×	10.6×	13.4×
2016	13.6×	11.7×	21.9×
2015	24.5×	22.9×	73.2×
2014	73.0×	23.7×	73.0×
2013	22.9×	19.8×	86.2×
2012	40.4×	40.0×	48.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Angiodynamics' size, closest first, today.

Company	Price to free cash flow
ANGOAngiodynamics	360×
TCMDTactile Systems Technology	20.0×
MDXGMimedx	n/m
MOVMovado	9.8×
EMBCEmbecta	2.3×
INFUInfuSystem	12.1×
IRMDIradimed	43.7×
STAAStaar Surgical	n/m
UTMDUtah Medical Products	20.6×
BVSBioventus	13.3×
CDRECadre	16.4×
Peer median	14.9×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Angiodynamics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.